
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2 | -13.986013986 | 1.43 | 1.55 | 1.17 | 13526 | 1.37031858 | CS |
4 | -0.26 | -17.4496644295 | 1.49 | 1.7486 | 1.17 | 11802 | 1.49200668 | CS |
12 | -0.36 | -22.641509434 | 1.59 | 1.85 | 0.8001 | 33275 | 1.41109328 | CS |
26 | -0.85 | -40.8653846154 | 2.08 | 3.08 | 0.8001 | 19169 | 1.56449102 | CS |
52 | -1.58 | -56.2277580071 | 2.81 | 3.3 | 0.8001 | 12418 | 1.79048272 | CS |
156 | -5.74 | -82.3529411765 | 6.97 | 7.88 | 0.8001 | 10638 | 2.71331293 | CS |
260 | -6.15 | -83.3333333333 | 7.38 | 9.33 | 0.8001 | 11177 | 3.84091883 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions